Abnormal TACC3 Expression is an Independent Prognostic Biomarker in Lung Carcinoma

Abnormal TACC3 Expression is an Independent Prognostic Biomarker in Lung Carcinoma

Objective: Abnormal expression of transforming acidic coiled-coil protein 3 (TACC3) has been reported in many types of human malignancies. However, the expression of TACC3 and its clinical significance have not been well characterized in lung carcinoma (LUAD). The aim of this study was to investigat...

Full description

Bibliographic Details
Main Authors:	Xiangmei Zhang, Xiaoyan Fan, Xin Li, Yaping Wang, Yulong Zhang, You Li, Jidong Zhao, Dongwei He
Format:	Article
Language:	English
Published:	IMR Press 2022-08-01
Series:	Frontiers in Bioscience-Landmark
Subjects:	tacc3 prognosis survival outcome lung carcinoma (luad)
Online Access:	https://www.imrpress.com/journal/FBL/27/8/10.31083/j.fbl2708252

Similar Items

The prognostic activity of transforming acidic coiled-coil 3 (TACC3) immunohistochemical expression in colon adenocarcinoma patients
by: Marlena Brzozowa-Zasada, et al.
Published: (2022-08-01)

FGFR3-TACCs3 Fusions and Their Clinical Relevance in Human Glioblastoma
by: Hanna Gött, et al.
Published: (2022-08-01)

Successful Treatment and Retreatment With Erdafitinib for a Patient With FGFR3-TACC3 Fusion Squamous NSCLC: A Case Report
by: Chi Pham, BSc, et al.
Published: (2023-05-01)

Determinan Rujukan Non Spesialistik Dengan Kriteria TACC di FKTP Kabupaten Batang Hari Tahun 2022
by: Bathari Yanthi, et al.
Published: (2023-06-01)

Salidroside inhibits the proliferation and epithelial mesenchymal transformation of NSCLC cell by negatively regulation of TACC2 expression
by: HE Shao-bo, LUO Fu-hua, JIANG Chuan-ming, LIU Xuan-mei
Published: (2022-11-01)

Coexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases
by: Leomar Y. Ballester, et al.
Published: (2019-04-01)

EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates
by: Kui Fan, et al.
Published: (2023-04-01)

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
by: Wentao Zhang, et al.
Published: (2023-08-01)

Diffuse Gliomas with FGFR3-TACC3 Fusions: Oncogenic Mechanisms, Hallmarks, and Therapeutic Perspectives
by: Alberto Picca, et al.
Published: (2023-11-01)

Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusion
by: Alice Métais, et al.
Published: (2023-01-01)

MMR gene patterns evaluation provides novel insights for personalized immunotherapy compared to neoadjuvant chemotherapy in lung adenocarcinama
by: Liangliang Cai, et al.
Published: (2023-06-01)

Clinicopathological and Molecular Characteristics of <i>IDH</i>-Wildtype Glioblastoma with <i>FGFR3::TACC3</i> Fusion
by: Hyunsik Bae, et al.
Published: (2024-01-01)

MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma
by: Yangyang Hu, et al.
Published: (2023-02-01)

MDFI is a novel biomarker for poor prognosis in LUAD
by: Pengyu Chen, et al.
Published: (2022-10-01)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
by: Linbin Hua, et al.
Published: (2023-05-01)

Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
by: Xiaoqing Ma, et al.
Published: (2023-11-01)

Identification of four metabolic subtypes and key prognostic markers in lung adenocarcinoma based on glycolytic and glutaminolytic pathways
by: Jinjin Zhang, et al.
Published: (2023-02-01)

Overexpression of SLC35F2 is a potential prognostic biomarker for lung adenocarcinoma
by: Qingzhu Zheng, et al.
Published: (2024-01-01)

NcRNA-regulated CAPZA1 associated with prognostic and immunological effects across lung adenocarcinoma
by: Tingting Qin, et al.
Published: (2023-01-01)

Linc00996 is a favorable prognostic factor in LUAD: Results from bioinformatics analysis and experimental validation
by: Zhenghai Shen, et al.
Published: (2022-09-01)

A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma
by: Jin-xiao Liang, et al.
Published: (2022-12-01)

Function and prognostic value of basement membrane -related genes in lung adenocarcinoma
by: Yurong Zhang, et al.
Published: (2023-05-01)

Integrated analysis of purine metabolism assists in predicting prognosis and treatment decisions for patients with lung adenocarcinoma
by: Tingting Zhang, et al.
Published: (2024-04-01)

LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response
by: Jihong Huang, et al.
Published: (2022-11-01)

Prenatal diagnosis of a 1.6-Mb 4p16.3 interstitial microdeletion encompassing FGFRL1 and TACC3 associated with bilateral cleft lip and palate of Wolf-Hirschhorn syndrome facial dysmorphism and short long bones
by: Chih-Ping Chen, et al.
Published: (2017-12-01)

The screening of immune-related biomarkers for prognosis of lung adenocarcinoma
by: Zhonghui Liu, et al.
Published: (2021-01-01)

Prognostic and Immunological Implications of FAM72A in Pan-Cancer and Functional Validations
by: Yuwen Bai, et al.
Published: (2022-12-01)

Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma
by: Guiping Wang, et al.
Published: (2020-02-01)

Unravelling the Role of LncRNA WT1-AS/miR-206/NAMPT Axis as Prognostic Biomarkers in Lung Adenocarcinoma
by: Wen Li, et al.
Published: (2021-02-01)

Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma
by: Junfeng Li, et al.
Published: (2023-01-01)

Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma
by: Quan Gong, et al.
Published: (2023-03-01)

Elevated ADAR expression is significantly linked to shorter overall survival and immune infiltration in patients with lung adenocarcinoma
by: Siqi Hu, et al.
Published: (2023-09-01)

The Tumorigenic Effect of the High Expression of Ladinin-1 in Lung Adenocarcinoma and Its Potential as a Therapeutic Target
by: Lei Hu, et al.
Published: (2023-01-01)

A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis
by: Fanming Kong, et al.
Published: (2023-11-01)

Prognostic correlation between specialized capillary endothelial cells and lung adenocarcinoma
by: Rongchang Zhao, et al.
Published: (2024-03-01)

Immune and non-immune cell subtypes identify novel targets for prognostic and therapeutic strategy: A study based on intratumoral heterogenicity analysis of multicenter scRNA-seq datasets in lung adenocarcinoma
by: Tianyu Fan, et al.
Published: (2022-11-01)

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
by: Fang Zhang, et al.
Published: (2023-02-01)

Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma
by: Hui Jia, et al.
Published: (2023-01-01)

m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma
by: Guangyao Wang, et al.
Published: (2022-08-01)

Identification of IRAK1BP1 as a candidate prognostic factor in lung adenocarcinoma
by: Lei Guo, et al.
Published: (2023-03-01)